These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7200770)

  • 1. Instability of (ara-C) DNA under alkaline conditions.
    Major PP; Egan EM; Herrick D; Kufe DW
    Biochem Pharmacol; 1982 Mar; 31(5):861-6. PubMed ID: 7200770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkali lability of deoxyribonucleic acid that contains adenine arabinoside.
    Egan EM; Justi-Wheeler H; Kufe DW
    Biochem Pharmacol; 1983 Dec; 32(24):3849-52. PubMed ID: 6661257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of cytotoxicity with incorporation of ara-C into DNA.
    Kufe DW; Major PP; Egan EM; Beardsley GP
    J Biol Chem; 1980 Oct; 255(19):8997-900. PubMed ID: 7410404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.
    Ross DD; Cuddy DP; Cohen N; Hensley DR
    Cancer Chemother Pharmacol; 1992; 31(1):61-70. PubMed ID: 1458561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells.
    Major PP; Egan EM; Herrick DJ; Kufe DW
    Biochem Pharmacol; 1982 Sep; 31(18):2937-40. PubMed ID: 7138584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
    Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Ara-C action: biochemical consideration.
    Rustum YM; Slocum HK; Li ZR
    Prog Clin Biol Res; 1983; 132E():107-20. PubMed ID: 6689076
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ; Kufe DW
    Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of action of cytosine arabinoside.
    Kufe DW; Major PP
    Med Pediatr Oncol; 1982; 10 Suppl 1():49-67. PubMed ID: 6761569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of chlorambucil-DNA adducts.
    Bank BB
    Biochem Pharmacol; 1992 Aug; 44(3):571-5. PubMed ID: 1510704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD; Chen SR; Cuddy DP
    Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular distribution of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in blood cells.
    Ueda T; Nakamura T; Kagawa D; Yamamoto K; Uchida M; Sasada M; Uchino H
    Gan; 1983 Jun; 74(3):445-51. PubMed ID: 6884702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction between etoposide and 1-beta-D-arabinofuranosylcytosine.
    Ohkubo T; Hori H; Higashigawa M; Kawasaki H; Kamiya H; Sakurai M; Kagawa Y; Kakito E; Sumida K; Ooi K
    Adv Exp Med Biol; 1989; 253B():355-62. PubMed ID: 2610123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
    Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.
    Raza A; Gezer S; Anderson J; Lykins J; Bennett J; Browman G; Goldberg J; Larson R; Vogler R; Preisler HD
    Exp Hematol; 1992 Nov; 20(10):1194-200. PubMed ID: 1426099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells.
    D'Incalci M; Covey JM; Zaharko DS; Kohn KW
    Cancer Res; 1985 Jul; 45(7):3197-202. PubMed ID: 2408746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of N4-behenoyl-1-beta-D-arabinofuranosylcytosine into DNA as 1-beta-D-arabinofuranosylcytosine.
    Higashigawa M; Ochiai H; Ohkubo T; Kawasaki H; Nobori T; Kamiya H; Sakurai M
    Med Oncol Tumor Pharmacother; 1988; 5(4):265-71. PubMed ID: 2848163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.